<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-2304442315458153295</id><updated>2011-11-28T01:36:56.024+01:00</updated><category term='Alzheimer&apos;s disease'/><category term='cancer'/><category term='cell growth arrest'/><category term='miRNA'/><category term='gene discovery'/><category term='miR-155'/><category term='neuronal cells'/><category term='cadherin'/><category term='Netrin-1'/><category term='mir 199'/><category term='Drosophila melanogaster'/><category term='CAGE'/><category term='cognitive impairment'/><category term='high-throughput'/><category term='ERK  kinase'/><category term='MNT-1 cells'/><category term='anti-correlated expression'/><category term='acute lymphoid leukemia'/><category term='endothelial cell'/><category term='synaptogenesis'/><category term='learning disability'/><category term='microRNA'/><category term='Fabp7'/><category term='regulation of transcription'/><category term='miRNA target sites'/><category term='copy number variation'/><category term='craniofacial dysmorphy'/><category term='New Category'/><category term='RNAseIII'/><category term='review'/><category term='oligonucleotide'/><category term='Dgcr8'/><category term='trisomy 21'/><category term='meiosis'/><category term='stem cells'/><category term='off-target effect'/><category term='ENCODE'/><category term='miRNA host genes'/><category term='meiotic spindle'/><category term='miRNA seed'/><category term='Down syndrome'/><category term='p65'/><category term='pigment'/><category term='regulation of expression'/><category term='miRNA processing'/><category term='LooptomiR'/><category term='helicase domain'/><category term='microdeletion'/><category term='book index'/><category term='B-cell maturation'/><category term='stable duplex'/><category term='ES cells'/><category term='WAGR syndrome'/><category term='deadenylation'/><category term='heart'/><category term='PCR'/><category term='Watson-Crick pairing'/><category term='seed region'/><category term='GMUCT'/><category term='ADAM10'/><category term='mental retardation'/><category term='DExH motif'/><category term='Pak1'/><category term='neuroblastoma'/><category term='ncRNA'/><category term='Fyn'/><category term='genital abnormalities'/><category term='small RNAs'/><category term='neuron projection'/><category term='DSCAM'/><category term='long-hairpin RNAs'/><category term='microarray'/><category term='TPA'/><category term='synaptic transmission'/><category term='pri-miRNA'/><category term='Dicer'/><category term='amyloid precursor protein'/><category term='aneuploidy'/><category term='cell growth'/><category term='degradome sequencing'/><category term='miRNA expression'/><category term='human chromosome 11'/><category term='plasticity'/><category term='multipotent stromal cells'/><category term='down syndrome chromosome 1'/><category term='allelic imbalance'/><category term='transient myeloproliferative disease'/><category term='protein kinase C'/><category term='CleaveLand'/><category term='Alzheimer disease'/><category term='3&apos;UTR'/><category term='cell development'/><category term='hematopoiesis'/><category term='miR-21'/><category term='heterochromatic DNA'/><category term='macroRNA'/><category term='dendrite arborization'/><category term='siRNA'/><category term='stems in microRNAs'/><category term='exonucleolytic digestion'/><category term='MAP kinase'/><category term='nuclear factor-kappa-B'/><category term='RT-qPCR'/><category term='prediction'/><category term='missegregation'/><category term='functional genomics'/><category term='macrocytosis'/><category term='noncoding RNA'/><category term='PI3K'/><category term='REST'/><category term='eponym'/><category term='PKC'/><category term='migration'/><category term='antagomir'/><category term='chromosome segregation'/><category term='seizure'/><category term='mRNA'/><category term='Potocki-Shaffer syndrome'/><category term='cataract'/><category term='first meiotic division'/><category term='proliferation'/><category term='immunoglobulin'/><category term='CAF1-CCR4-NOT1'/><category term='motility'/><category term='decapping'/><category term='mir346'/><category term='skin'/><category term='G:U pair'/><category term='short-hairpin RNAs'/><category term='transcriptional repressor'/><category term='transcription factors'/><category term='HOCTAR'/><category term='protein PU.1'/><category term='primary melanocytes'/><category term='acute megakaryocytic leukemia'/><category term='TargetScan'/><category term='axon guidance'/><category term='promoter'/><category term='LIF'/><category term='GF109203X'/><category term='RNAi'/><title type='text'>Down syndrome blog</title><subtitle type='html'>Hi, I am going to bring abstracts of articles that are connected to the Down syndrome and small RNA research.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>42</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7416363003904851353</id><published>2009-07-29T17:23:00.001+02:00</published><updated>2009-07-29T17:23:40.071+02:00</updated><title type='text'>The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies</title><content type='html'>&lt;p&gt;&lt;a href="http://www.pnas.org/cgi/content/short/0813248106v1?rss=1"&gt;Article&lt;/a&gt;: &lt;p&gt;Down syndrome (DS), or trisomy 21, is a common disorder associated with several complex clinical phenotypes. Although several hypotheses have been put forward, it is unclear as to whether particular gene loci on chromosome 21 (HSA21) are sufficient to cause DS and its associated features. Here we present a high-resolution genetic map of DS phenotypes based on an analysis of 30 subjects carrying rare segmental trisomies of various regions of HSA21. By using state-of-the-art genomics technologies we mapped segmental trisomies at exon-level resolution and identified discrete regions of 1.8-16.3 Mb likely to be involved in the development of 8 DS phenotypes, 4 of which are congenital malformations, including acute megakaryocytic leukemia, transient myeloproliferative disorder, Hirschsprung disease, duodenal stenosis, imperforate anus, severe mental retardation, DS-Alzheimer Disease, and DS-specific congenital heart disease (DSCHD). Our DS-phenotypic maps located DSCHD to a &lt; 2-Mb interval. Furthermore, the map enabled us to present evidence against the necessary involvement of other loci as well as specific hypotheses that have been put forward in relation to the etiology of DS-i.e., the presence of a single DS consensus region and the sufficiency of DSCR1 and DYRK1A, or APP, in causing several severe DS phenotypes. Our study demonstrates the value of combining advanced genomics with cohorts of rare patients for studying DS, a prototype for the role of copy-number variation in complex disease.
"&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.pnas.org"&gt;PNAS - RSS feed of Early Edition articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7416363003904851353?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7416363003904851353/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/07/genetic-architecture-of-down-syndrome.html#comment-form' title='42 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7416363003904851353'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7416363003904851353'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/07/genetic-architecture-of-down-syndrome.html' title='The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>42</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-4448816442410992334</id><published>2009-06-24T16:18:00.001+02:00</published><updated>2009-06-24T16:18:09.613+02:00</updated><title type='text'>ERG Is a Megakaryocytic Oncogene</title><content type='html'>&lt;p&gt;&lt;a href="http://cancerres.aacrjournals.org/cgi/content/short/69/11/4665?rss=1"&gt;Original article&lt;/a&gt;:&lt;p&gt;Ets-related gene (&lt;I&gt;ERG&lt;/I&gt;) is a member of the &lt;I&gt;ETS&lt;/I&gt; transcription factor gene family located on Hsa21. &lt;I&gt;ERG&lt;/I&gt; is known to have a crucial role in establishing definitive hematopoiesis and is required for normal megakaryopoiesis. Truncated forms of &lt;I&gt;ERG&lt;/I&gt; are associated with multiple cancers such as Ewing's sarcoma, prostate cancer, and leukemia as part of oncogenic fusion translocations. Increased expression of &lt;I&gt;ERG&lt;/I&gt; is highly indicative of poor prognosis in acute myeloid leukemia and &lt;I&gt;ERG&lt;/I&gt; is expressed in acute megakaryoblastic leukemia (AMKL); however, it is unclear if expression of &lt;I&gt;ERG&lt;/I&gt; per se has a leukemogenic activity. We show that ectopic expression of &lt;I&gt;ERG&lt;/I&gt; in fetal hematopoietic progenitors promotes megakaryopoiesis and that &lt;I&gt;ERG&lt;/I&gt; alone acts as a potent oncogene &lt;I&gt;in vivo&lt;/I&gt; leading to rapid onset of leukemia in mice. We observe that the endogenous &lt;I&gt;ERG&lt;/I&gt; is required for the proliferation and maintenance of AMKL cell lines. &lt;I&gt;ERG&lt;/I&gt; also strongly cooperates with the GATA1s mutated protein, found in Down syndrome AMKL, to immortalize megakaryocyte progenitors, suggesting that the additional copy of &lt;I&gt;ERG&lt;/I&gt; in trisomy 21 may have a role in Down syndrome AMKL. These data suggest that &lt;I&gt;ERG&lt;/I&gt; is a hematopoietic oncogene that may play a direct role in myeloid leukemia pathogenesis. [Cancer Res 2009;69(11):4665-73]&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://cancerres.aacrjournals.org"&gt;Cancer Research recent issues&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-4448816442410992334?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/4448816442410992334/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/erg-is-megakaryocytic-oncogene.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4448816442410992334'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4448816442410992334'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/erg-is-megakaryocytic-oncogene.html' title='ERG Is a Megakaryocytic Oncogene'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-9125390940956473198</id><published>2009-06-24T16:12:00.001+02:00</published><updated>2009-06-24T16:12:50.671+02:00</updated><title type='text'>[Medical_Sciences] Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses</title><content type='html'>&lt;p&gt;&lt;a href="http://www.pnas.org/cgi/content/short/0903909106v1?rss=1"&gt;Original article&lt;/a&gt;:&lt;p&gt;To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples. Functional pathway analysis highlighted the importance of oxidative stress, ion transport, and G protein signaling in the DS fetuses. Further evidence supporting these results was derived by correlating the observed gene expression patterns to those of small molecule drugs via the Connectivity Map. Our results suggest that there are secondary adverse consequences of DS evident in the second trimester, leading to testable hypotheses about possible antenatal therapy for DS.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.pnas.org"&gt;PNAS - RSS feed of Early Edition articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-9125390940956473198?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/9125390940956473198/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/medicalsciences-functional-genomic.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/9125390940956473198'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/9125390940956473198'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/medicalsciences-functional-genomic.html' title='[Medical_Sciences] Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-1684350328615985331</id><published>2009-06-24T14:58:00.001+02:00</published><updated>2009-06-24T14:58:38.153+02:00</updated><title type='text'>Inverted duplications on acentric markers: mechanism of formation</title><content type='html'>&lt;p&gt;&lt;a href="http://hmg.oxfordjournals.org/cgi/content/short/18/12/2241?rss=1"&gt;Original article&lt;/a&gt;:&lt;p&gt;Acentric inverted duplication (inv dup) markers, the largest group of chromosomal abnormalities with neocentromere formation, are found in patients both with idiopathic mental retardation and with cancer. The mechanism of their formation has been investigated by analyzing the breakpoints and the genotypes of 12 inv dup marker cases (three trisomic, six tetrasomic, two polysomic and one X chromosome derived marker) using a combination of fluorescence &lt;I&gt;in situ&lt;/I&gt; hybridization, quantitative SNP array and microsatellite analysis. Inv dup markers were found to form either symmetrically with one breakpoint or asymmetrically with two distinct breakpoints. Genotype analyses revealed that all inv dup markers formed from one single chromatid end. This observation is incompatible with the previously suggested model by which the acentric inv dup markers form through inter-chromosomal U-type exchange. On the basis of the identification of DNA sequence motifs with inverted homologies within all observed breakpoint regions, a new general mechanism is proposed for the acentric inv dup marker formation: following a double-strand break an acentric fragment forms, during either meiosis or mitosis. The open DNA end of the acentric fragment is stabilized by the formation of an intra-chromosomal loop promoted by the presence of sequences with inverted homologies. Likely coinciding with the neocentromere formation, this stabilized fragment is duplicated during an early mitotic event, insuring the marker’s survival during cell division and its presence in all cells.&lt;/p&gt;"&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://hmg.oxfordjournals.org"&gt;Human Molecular Genetics - recent issues&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-1684350328615985331?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/1684350328615985331/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/inverted-duplications-on-acentric.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1684350328615985331'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1684350328615985331'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/inverted-duplications-on-acentric.html' title='Inverted duplications on acentric markers: mechanism of formation'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-640034414236043334</id><published>2009-06-24T14:49:00.001+02:00</published><updated>2009-06-24T14:49:59.766+02:00</updated><title type='text'>Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease</title><content type='html'>&lt;p&gt;&lt;a href="http://bioinformatics.oxfordjournals.org/cgi/content/short/25/10/1244?rss=1"&gt;Original article&lt;/a&gt;:&lt;p&gt;There is currently great interest in the development of methods for the minimally invasive diagnosis of fetal genetic disease using cell-free DNA from maternal plasma samples obtained in the first trimester of pregnancy. With the rapid development of high-throughput sequencing technology, the possibility of detecting the presence of trisomy fetal genomes in the maternal plasma DNA sample has recently been explored. The major concern of this whole genome sequencing approach is that, while detecting the karyotype of the fetal genome from the maternal plasma requires extremely high accuracy of copy number estimation, the majority of the available high-throughput sequencing technologies require polymerase chain reaction (PCR) and are subject to the substantial bias that is inherent to the PCR process. We introduce a novel and sophisticated statistical model for the whole genome sequencing data, and based on this model, develop a highly sensitive method of Minimally Invasive Karyotyping (MINK) for the diagnosis of the fetal genetic disease. Specifically we demonstrate, by applying our statistical method to ultra high-throughput whole sequencing data, that trisomy 21 can be detected in a minor (‘fetal’) genome when it is mixed into a major (‘maternal’) background genome at frequencies as low as 5%. This observation provides additional proof of concept and justification for the further development of this method towards its eventual clinical application. Here, we describe the statistical and experimental methods that illustrate this approach and discuss future directions for technical development and potential clinical applications.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Contact:&lt;/b&gt; &lt;inter-ref locator="dgp6@pitt.edu" locator-type="email"&gt;dgp6@pitt.edu&lt;/inter-ref&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Supplementary information:&lt;/b&gt; &lt;inter-ref locator="http://bioinformatics.oxfordjournals.org/cgi/content/full/btp156/DC1" locator-type="url"&gt;Supplementary data&lt;/inter-ref&gt; are available at &lt;I&gt;Bioinformatics&lt;/I&gt; online.&lt;/p&gt;"&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://bioinformatics.oxfordjournals.org"&gt;Bioinformatics - current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-640034414236043334?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/640034414236043334/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/statistical-model-for-whole-genome.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/640034414236043334'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/640034414236043334'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/statistical-model-for-whole-genome.html' title='Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-4993811781350614423</id><published>2009-06-24T14:42:00.001+02:00</published><updated>2009-06-24T14:42:43.330+02:00</updated><title type='text'>DNA Methylation Analysis of Chromosome 21 Gene Promoters at Single Base Pair and Single Allele Resolution</title><content type='html'>&lt;p&gt;&lt;a href="http://feedproxy.google.com/~r/plosgenetics/NewArticles/~3/rJm5TQ7G9X4/info%3Adoi%2F10.1371%2Fjournal.pgen.1000438"&gt;Original article&lt;/a&gt;:&lt;p&gt;

&lt;p xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:util="http://dtd.nlm.nih.gov/xsl/util" xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:mml="http://www.w3.org/1998/Math/MathML"&gt;Epigenetics is defined as the inheritance of changes in gene function without changing the DNA sequence. Epigenetic signals comprise methylation of cytosine bases of the DNA and chemical modifications of the histone proteins. DNA methylation plays important roles in development and disease processes. To investigate the biological role of DNA methylation, we analyzed DNA methylation patterns of 190 gene promoter regions on chromosome 21 in five human cell types. Our results show that average DNA methylation levels are distributed bimodally with enrichment of highly methylated and unmethylated sequences, indicating that DNA methylation acts in a switch-like manner. Consistent with the well-established role of DNA methylation in gene silencing, we found DNA methylation in promoter regions strongly correlated with absence of gene expression and low levels of additional activating epigenetic marks. Although methylation levels of individual cells in one tissue are very similar, we observed differences in DNA methylation when comparing different cell types in 43% of all regions analyzed. This finding is in agreement with a role of DNA methylation in cellular development. We identified three cases of genes that are differentially methylated in both alleles that illustrate the tight interplay of genetic and epigenetic processes.&lt;/p&gt;&lt;img src="http://feeds2.feedburner.com/~r/plosgenetics/NewArticles/~4/rJm5TQ7G9X4" height="1" width="1"/&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://genetics.plosjournals.org/perlserv/?request=get-rss&amp;amp;issn=1553-7404&amp;amp;type=new-articles"&gt;PLoS Genetics: Archived Table of Contents&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-4993811781350614423?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/4993811781350614423/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/dna-methylation-analysis-of-chromosome.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4993811781350614423'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4993811781350614423'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/06/dna-methylation-analysis-of-chromosome.html' title='DNA Methylation Analysis of Chromosome 21 Gene Promoters at Single Base Pair and Single Allele Resolution'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-2079172179367152644</id><published>2009-03-20T16:50:00.001+01:00</published><updated>2009-03-20T16:50:32.262+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='craniofacial dysmorphy'/><category scheme='http://www.blogger.com/atom/ns#' term='hematopoiesis'/><category scheme='http://www.blogger.com/atom/ns#' term='heart'/><category scheme='http://www.blogger.com/atom/ns#' term='acute lymphoid leukemia'/><category scheme='http://www.blogger.com/atom/ns#' term='trisomy 21'/><category scheme='http://www.blogger.com/atom/ns#' term='macrocytosis'/><category scheme='http://www.blogger.com/atom/ns#' term='acute megakaryocytic leukemia'/><category scheme='http://www.blogger.com/atom/ns#' term='transient myeloproliferative disease'/><category scheme='http://www.blogger.com/atom/ns#' term='Down syndrome'/><category scheme='http://www.blogger.com/atom/ns#' term='cognitive impairment'/><title type='text'>Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome</title><content type='html'>&lt;p&gt;&lt;a href="http://bloodjournal.hematologylibrary.org/cgi/content/short/113/12/2619?rss=1"&gt;Original article&lt;/a&gt;:&lt;p&gt;Children with Down syndrome (DS) show a spectrum of clinical anomalies, including cognitive impairment, cardiac malformations, and craniofacial dysmorphy. Moreover, hematologists have also noted that these children commonly show macrocytosis, abnormal platelet counts, and an increased incidence of transient myeloproliferative disease (TMD), acute megakaryocytic leukemia (AMKL), and acute lymphoid leukemia (ALL). 

&lt;p&gt;In this review, we summarize the clinical manifestations and characteristics of these leukemias, provide an update on therapeutic strategies and patient outcomes, and discuss the most recent advances in DS-leukemia research. With the increased knowledge of the way in which trisomy 21 affects hematopoiesis and the specific genetic mutations that are found in DS-associated leukemias, we are well on our way toward designing improved strategies for treating both myeloid and lymphoid malignancies in this high-risk population.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://bloodjournal.hematologylibrary.org"&gt;Blood recent issues&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-2079172179367152644?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/2079172179367152644/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/insights-into-manifestations-outcomes.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2079172179367152644'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2079172179367152644'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/insights-into-manifestations-outcomes.html' title='Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-8350278610694682836</id><published>2009-03-20T16:46:00.001+01:00</published><updated>2009-03-20T16:46:24.066+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='heart'/><category scheme='http://www.blogger.com/atom/ns#' term='learning disability'/><category scheme='http://www.blogger.com/atom/ns#' term='trisomy 21'/><category scheme='http://www.blogger.com/atom/ns#' term='Alzheimer&apos;s disease'/><category scheme='http://www.blogger.com/atom/ns#' term='review'/><category scheme='http://www.blogger.com/atom/ns#' term='Down syndrome'/><title type='text'>Down syndrome--recent progress and future prospects</title><content type='html'>&lt;p&gt;&lt;a href="http://hmg.oxfordjournals.org/cgi/content/short/18/R1/R75?rss=1"&gt;Original article&lt;/a&gt;:

&lt;p&gt;Down syndrome (DS) is caused by trisomy of chromosome 21 (Hsa21) and is associated with a number of deleterious phenotypes, including learning disability, heart defects, early-onset Alzheimer's disease and childhood leukaemia. Individuals with DS are affected by these phenotypes to a variable extent; understanding the cause of this variation is a key challenge. &lt;/p&gt;

&lt;p&gt;Here, we review recent research progress in DS, both in patients and relevant animal models. In particular, we highlight exciting advances in therapy to improve cognitive function in people with DS and the significant developments in understanding the gene content of Hsa21. Moreover, we discuss future research directions in light of new technologies. In particular, the use of chromosome engineering to generate new trisomic mouse models and large-scale studies of genotype-phenotype relationships in patients are likely to significantly contribute to the future understanding of DS.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://hmg.oxfordjournals.org"&gt;Human Molecular Genetics - current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-8350278610694682836?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/8350278610694682836/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/down-syndrome-recent-progress-and.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8350278610694682836'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8350278610694682836'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/down-syndrome-recent-progress-and.html' title='Down syndrome--recent progress and future prospects'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-2763844452490590655</id><published>2009-03-13T19:09:00.001+01:00</published><updated>2009-03-13T19:09:59.645+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='chromosome segregation'/><category scheme='http://www.blogger.com/atom/ns#' term='first meiotic division'/><category scheme='http://www.blogger.com/atom/ns#' term='trisomy 21'/><category scheme='http://www.blogger.com/atom/ns#' term='meiosis'/><category scheme='http://www.blogger.com/atom/ns#' term='Down syndrome'/><category scheme='http://www.blogger.com/atom/ns#' term='missegregation'/><category scheme='http://www.blogger.com/atom/ns#' term='aneuploidy'/><title type='text'>Regulation of APC/C Activity in Oocytes by a Bub1-Dependent Spindle Assembly Checkpoint</title><content type='html'>&lt;p&gt;&lt;a href="http://www.cell.com/current-biology/abstract/S0960-9822(09)00685-X"&gt;Original article&lt;/a&gt;

&lt;p&gt;Barry E. McGuinness, Martin Anger, Anna Kouznetsova, Ana M. Gil-Bernabé, Wolfgang Helmhart, Nobuaki R. Kudo, Annelie Wuensche, Stephen Taylor, Christer Hoog, Bela Novak, Kim Nasmyth.&lt;/p&gt;

&lt;p&gt;Summary&lt;/p&gt;

&lt;p&gt;Missegregation of chromosomes during meiosis in human females causes aneuploidy, including trisomy 21, and is thought also to be the major cause of age-related infertility [1]. Most errors are thought to occur at the first meiotic division. The high frequency of errors raises questions as to whether the surveillance mechanism known as the spindle assembly checkpoint (SAC) that controls the anaphase-promoting complex or cyclosome (APC/C) operates effectively in oocytes.&lt;/p&gt; 

&lt;p&gt;Experimental approaches hitherto used to inactivate the SAC in oocytes suffer from a number of drawbacks.Bub1 protein was depleted specifically in oocytes with a Zp3-Cre transgene to delete exons 7 and 8 from a floxed BUB1F allele. Loss of Bub1 greatly accelerates resolution ofchiasmata and extrusion of polar bodies. It also causes defective biorientation of bivalents, massive chromosome missegregation at meiosis I, and precocious loss of cohesion between sister centromeres. &lt;/p&gt;

&lt;p&gt;By using a quantitative assay forAPC/C-mediated securin destruction, we show that the APC/C is activated in an exponential fashion, with activity peaking 1213 hr after GVBD, and that this process is advanced by 5hr in oocytes lacking Bub1. Importantly, premature chiasmata resolution does not occur in Bub1-deficient oocytes also lacking either the APC/C's Apc2 subunit or separase. &lt;/p&gt;

&lt;p&gt;Finally, we show that Bub1's kinase domain is not required to delay APC/C activation.We conclude that far from being absent or ineffective, the SAC largely determines the timing of APC/C and hence separase activation in oocytes, delaying it for about 5 hr.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.cell.com"&gt;Current Biology&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-2763844452490590655?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/2763844452490590655/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/regulation-of-apcc-activity-in-oocytes.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2763844452490590655'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2763844452490590655'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/regulation-of-apcc-activity-in-oocytes.html' title='Regulation of APC/C Activity in Oocytes by a Bub1-Dependent Spindle Assembly Checkpoint'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-8275914636851102096</id><published>2009-03-13T19:04:00.001+01:00</published><updated>2009-03-13T19:04:39.581+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='book index'/><category scheme='http://www.blogger.com/atom/ns#' term='eponym'/><category scheme='http://www.blogger.com/atom/ns#' term='New Category'/><category scheme='http://www.blogger.com/atom/ns#' term='Down syndrome'/><title type='text'>Current use of medical eponyms - a need for global uniformity in scientific publications</title><content type='html'>&lt;p&gt;&lt;a href="http://www.biomedcentral.com/1471-2288/9/18"&gt;Original article&lt;/a&gt;

&lt;p&gt;Background:&lt;/p&gt;

&lt;p&gt;Although eponyms are widely used in medicine, they arbitrarily alternate between the possessive and nonpossessive forms. As very little is known regarding extent and distribution of this variation, the present study was planned to assess current use of eponymous term taking 'Down syndrome' and 'Down's syndrome' as an example.&lt;/p&gt;
&lt;p&gt;Methods:&lt;/p&gt;
&lt;p&gt;This study was carried out in two phases - first phase in 1998 and second phase in 2008. In the first phase, we manually searched the terms 'Down syndrome' and 'Down's syndrome' in the indexes 70 medical books, and 46 medical journals. In second phase, we performed PubMed search with both the terms, followed by text-word search for the same.&lt;/p&gt;
&lt;p&gt;Results:&lt;/p&gt;
&lt;p&gt;In the first phase, there was an overall tilt towards possessive form - 62(53.4%) 'Down's syndrome' versus 54(46.6%) 'Down syndrome.' However, the American publications preferred the nonpossesive form when compared with their European counterpart (40/50 versus 14/66; P&lt;0.001). In the second phase, PubMed search showed, compared to "Down syndrome," term "Down's syndrome" yielded approximately 5% more articles. The text-word search of both forms between January 1970 and June 2008 showed a gradual shift from "Down's syndrome" to "Down syndrome," and over the last 20 years, the frequency of the former was approximately halved (33.7% versus 16.5%; P&lt;0.001). The abstracts having possessive form were mostly published from the European countries, while most American publications used nonpossesive form consistently. 
&lt;p&gt;Conclusions:&lt;/p&gt;
&lt;p&gt;Inconsistency in the use of medical eponyms remains a major problem in literature search. Because of linguistic simplicity and technical advantages, the nonpossessive form should be used uniformly worldwide."&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.biomedcentral.com"&gt;BioMed Central - Latest articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-8275914636851102096?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/8275914636851102096/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/current-use-of-medical-eponyms-need-for.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8275914636851102096'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8275914636851102096'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/current-use-of-medical-eponyms-need-for.html' title='Current use of medical eponyms - a need for global uniformity in scientific publications'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-3503844857567182251</id><published>2009-03-04T16:04:00.001+01:00</published><updated>2009-03-04T16:04:48.353+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='chromosome segregation'/><category scheme='http://www.blogger.com/atom/ns#' term='meiotic spindle'/><category scheme='http://www.blogger.com/atom/ns#' term='Drosophila melanogaster'/><category scheme='http://www.blogger.com/atom/ns#' term='heterochromatic DNA'/><category scheme='http://www.blogger.com/atom/ns#' term='meiosis'/><category scheme='http://www.blogger.com/atom/ns#' term='Down syndrome'/><title type='text'>Heterochromatic Threads Connect Oscillating Chromosomes during Prometaphase I in Drosophila Oocytes</title><content type='html'>&lt;p&gt;&lt;a href="http://www.plosgenetics.org/article/info:doi%2F10.1371%2Fjournal.pgen.1000348"&gt;Link to original article&lt;/a&gt;:

&lt;p&gt;Proper chromosome segregation is essential during the production of eggs and sperm. Chromosome missegregation during meiosis results in the lethality of the offspring or in children carrying extra copies of a given chromosome (for example, Down syndrome). Recombination results in homologous chromosomes becoming physically interlocked in a manner that is normally sufficient to ensure proper segregation. Chromosomes that fail to undergo recombination require additional mechanisms to ensure their proper segregation. &lt;/p&gt;

&lt;p&gt;In &lt;i&gt;Drosophila melanogaster&lt;/i&gt; oocytes we show that chromosomes that fail to recombine undergo dynamic movements on the meiotic spindle prior to their proper segregation. Although previous studies had shown that non-recombinant chromosomes move to opposite sides of the developing meiotic spindle, we show that these chromosomes can cross the spindle and re-associate with their homologs to attempt reorientation.&lt;/p&gt; 

&lt;p&gt;Additionally, we observed threads connecting separated non-recombinant chromosomes that contained heterochromatic DNA and passenger complex proteins. These threads could assist the non-recombinant chromosomes in locating their homologs during their dynamic movements on the spindle. These chromosome movements and the heterochromatic threads are likely part of the mechanism ensuring proper segregation of nonexchange chromosomes.&lt;/p&gt;
&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-3503844857567182251?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/3503844857567182251/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/heterochromatic-threads-connect.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/3503844857567182251'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/3503844857567182251'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/heterochromatic-threads-connect.html' title='Heterochromatic Threads Connect Oscillating Chromosomes during Prometaphase I in Drosophila Oocytes'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7525259536689376320</id><published>2009-03-04T15:54:00.001+01:00</published><updated>2009-03-04T16:05:08.783+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='cadherin'/><category scheme='http://www.blogger.com/atom/ns#' term='DSCAM'/><category scheme='http://www.blogger.com/atom/ns#' term='immunoglobulin'/><title type='text'>[Reviews] Dscam and DSCAM: complex genes in simple animals, complex animals yet simple genes</title><content type='html'>&lt;p&gt;&lt;a href="http://genesdev.cshlp.org/cgi/content/short/23/2/147?rss=1"&gt;Link to original article&lt;/a&gt;:

&lt;p&gt;Cadherins and the immunoglobulin (Ig) proteins give rise to a multitude of surface receptors, which function as diverse cell adhesion molecules (CAMs) or signal-transducing receptors. These functions are often interdependent, and rely on a high degree of specificity in homophilic binding as well as heterophilic interactions. The &lt;I&gt;Drosophila&lt;/I&gt; receptor Dscam is an exceptional example of homophilic binding specificity involved in a number of important biological processes, such as neural wiring and innate immunity.&lt;/p&gt; 

&lt;p&gt;Combinatorial use of alternatively spliced Ig-domains enables the generation of an estimated 18,000 isoform-specific homophilic receptor pairs. Although isoform diversity of Dscam is unique to arthropods, recent genetic analysis of vertebrate DSCAM (Down Syndrome Cell Adhesion Molecule) genes has revealed an intriguing conservation of molecular functions underlying neural wiring. &lt;/p&gt;

&lt;p&gt;This review covers the multiple functions of Dscam across different species highlighting its remarkable versatility as well as its conserved basic functions in neural development. We discuss how an unprecedented expansion of complex alternative splicing has been uniquely employed by arthropods to generate diverse surface receptors, important for cell-cell communication, molecular self-recognition in neurons, and innate immune defenses. We end with a speculative hypothesis reconciling the striking differences in Dscam and DSCAM gene structures with their conserved functions in molecular recognition underlying neural circuit formation.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://genesdev.cshlp.org"&gt;Genes &amp; Development current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7525259536689376320?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7525259536689376320/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/reviews-dscam-and-dscam-complex-genes.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7525259536689376320'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7525259536689376320'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/reviews-dscam-and-dscam-complex-genes.html' title='[Reviews] Dscam and DSCAM: complex genes in simple animals, complex animals yet simple genes'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-2651237444009838102</id><published>2009-03-04T15:48:00.001+01:00</published><updated>2009-03-04T15:51:22.335+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='amyloid precursor protein'/><category scheme='http://www.blogger.com/atom/ns#' term='neuron projection'/><category scheme='http://www.blogger.com/atom/ns#' term='synaptogenesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Alzheimer disease'/><category scheme='http://www.blogger.com/atom/ns#' term='ADAM10'/><category scheme='http://www.blogger.com/atom/ns#' term='synaptic transmission'/><category scheme='http://www.blogger.com/atom/ns#' term='Fabp7'/><title type='text'>Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice</title><content type='html'>&lt;p&gt;&lt;a href="http://www.biomedcentral.com/1471-2164/10/66"&gt;Link to original article&lt;/a&gt;

&lt;p&gt;Background
In a transgenic mouse model of Alzheimer disease (AD), cleavage of the amyloid precursor protein (APP) by the alpha-secretase ADAM10 prevented amyloid plaque formation, and alleviated cognitive deficits. Furthermore, ADAM10 overexpression increased the cortical synaptogenesis. These results suggest that upregulation of ADAM10 in the brain has beneficial effects on AD pathology.&lt;/p&gt;
&lt;p&gt;Results:
To assess the influence of ADAM10 on the gene expression profile in the brain, we performed a microarray analysis using RNA isolated from brains of five months old mice overexpressing either the alpha-secretase ADAM10, or a dominant-negative mutant (dn) of this enzyme. As compared to non-transgenic wild-type mice, in ADAM10 transgenic mice 355 genes, and in dnADAM10 mice 143 genes were found to be differentially expressed. A higher number of genes was differentially regulated in double-transgenic mouse strains additionally expressing the human APP[V717I] mutant. &lt;/p&gt;
&lt;p&gt;Overexpression of proteolytically active ADAM10 affected several physiological pathways, such as cell communication, nervous system development, neuron projection as well as synaptic transmission. Although ADAM10 has been implicated in Notch and beta-catenin signaling, no significant changes in the respective target genes were observed in adult ADAM10 transgenic mice.&lt;/p&gt;
&lt;p&gt;Real-time RT-PCR confirmed a downregulation of genes coding for the inflammation-associated proteins S100a8 and S100a9 induced by moderate ADAM10 overexpression. Overexpression of the dominant-negative form dnADAM10 led to a significant increase in the expression of the fatty acid-binding protein Fabp7, which also has been found in higher amounts in brains of Down Syndrome patients.&lt;/p&gt;
&lt;p&gt;Conclusion:
In general, there was only a moderate alteration of gene expression in ADAM10 overexpressing mice. Genes coding for pro-inflammatory or pro-apoptotic proteins were not over-represented among differentially regulated genes. Even a decrease of inflammation markers was observed. These results are further supportive for the strategy to treat AD by increasing the alpha-secretase activity.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.biomedcentral.com"&gt;BioMed Central - Latest articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-2651237444009838102?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/2651237444009838102/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/differential-gene-expression-in-adam10.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2651237444009838102'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2651237444009838102'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/differential-gene-expression-in-adam10.html' title='Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7684317726342373821</id><published>2009-03-04T14:50:00.001+01:00</published><updated>2009-03-04T14:50:22.653+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='dendrite arborization'/><category scheme='http://www.blogger.com/atom/ns#' term='Netrin-1'/><category scheme='http://www.blogger.com/atom/ns#' term='Fyn'/><category scheme='http://www.blogger.com/atom/ns#' term='down syndrome chromosome 1'/><category scheme='http://www.blogger.com/atom/ns#' term='DSCAM'/><category scheme='http://www.blogger.com/atom/ns#' term='Pak1'/><category scheme='http://www.blogger.com/atom/ns#' term='axon guidance'/><title type='text'>[Neuroscience] DSCAM functions as a netrin receptor in commissural axon pathfinding</title><content type='html'>&lt;p&gt;&lt;a href="http://www.pnas.org/cgi/content/short/106/8/2951?rss=1"&gt;Link to original article&lt;/a&gt;: &lt;p&gt;Down syndrome cell adhesion molecule (DSCAM) is required for axon guidance and dendrite arborization. How DSCAM functions in vertebrates is not well understood. Here we show that DSCAM is expressed on commissural axons and interacts with Netrin-1, a prototypical guidance cue for commissural axons. The knockdown of DSCAM by specific siRNA or blockage of DSCAM signaling by overexpression of a mutant lacking its intracellular domain inhibits netrin-induced axon outgrowth and commissural axon turning in vitro. SiRNA-mediated knockdown of DSCAM in ovo causes defects in commissural axon projection and pathfinding. In transfected cells, DSCAM by itself, in the absence of DCC, is capable of mediating netrin signaling in activating phosphorylation of Fyn and Pak1. These findings demonstrate an essential role of vertebrate DSCAM in axon guidance, indicating that DSCAM functions as a receptor of netrin-1. Our data suggest previously unexpected complexity in receptors that mediate vertebrate netrin signaling.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.pnas.org"&gt;Proceedings of the National Academy of Sciences recent issues&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7684317726342373821?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7684317726342373821/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/neuroscience-dscam-functions-as-netrin.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7684317726342373821'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7684317726342373821'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/03/neuroscience-dscam-functions-as-netrin.html' title='[Neuroscience] DSCAM functions as a netrin receptor in commissural axon pathfinding'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-3336329571177897807</id><published>2009-02-22T21:43:00.001+01:00</published><updated>2009-02-22T21:43:14.070+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='small RNAs'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA target sites'/><category scheme='http://www.blogger.com/atom/ns#' term='mRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='CleaveLand'/><category scheme='http://www.blogger.com/atom/ns#' term='GMUCT'/><category scheme='http://www.blogger.com/atom/ns#' term='prediction'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='degradome sequencing'/><title type='text'>CleaveLand: a pipeline for using degradome data to find cleaved small RNA targets</title><content type='html'>&lt;p&gt;&lt;a href="http://bioinformatics.oxfordjournals.org/cgi/content/short/25/1/130?rss=1"&gt;Link to original article&lt;/a&gt;&lt;p&gt;&lt;b&gt;Summary:&lt;/b&gt; MicroRNAs (miRNAs) are ~20- to 22-nt long endogenous RNA sequences that play a critical role in the regulation of gene expression in eukaryotic genomes. Confident identification of miRNA targets is vital to understand their functions. &lt;/p&gt;&lt;p&gt;Currently available computational algorithms for miRNA target prediction have diverse degrees of sensitivity and specificity and as a consequence each predicted target generally requires experimental confirmation. miRNAs and other small RNAs that direct endonucleolytic cleavage of target mRNAs produce diagnostic uncapped, polyadenylated mRNA fragments. &lt;/p&gt;&lt;p&gt;Degradome sequencing [also known as PARE (parallel analysis of RNA ends) and GMUCT (genome-wide mapping of uncapped transcripts)] samples the 5'-ends of uncapped mRNAs and can be used to discover &lt;I&gt;in vivo&lt;/I&gt; miRNA targets independent of computational predictions. &lt;/p&gt;&lt;p&gt;Here, we describe a generalizable computational pipeline, CleaveLand, for the detection of cleaved miRNA targets from degradome data. CleaveLand takes as input degradome sequences, small RNAs and an mRNA database and outputs small RNA targets. CleaveLand can thus be applied to degradome data from any species provided a set of mRNA transcripts and a set of query miRNAs or other small RNAs are available.&lt;/p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Availability:&lt;/b&gt; The code and documentation for CleaveLand is freely available under a GNU license at &lt;inter-ref locator="http://www.bio.psu.edu/people/faculty/Axtell/AxtellLab/Software.html" locator-type="url"&gt;http://www.bio.psu.edu/people/faculty/Axtell/AxtellLab/Software.html&lt;/inter-ref&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Contact:&lt;/b&gt; &lt;inter-ref locator="mja18@psu.edu" locator-type="email"&gt;mja18@psu.edu&lt;/inter-ref&gt;&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://bioinformatics.oxfordjournals.org"&gt;Bioinformatics - recent issues&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-3336329571177897807?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/3336329571177897807/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/cleaveland-pipeline-for-using-degradome.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/3336329571177897807'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/3336329571177897807'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/cleaveland-pipeline-for-using-degradome.html' title='CleaveLand: a pipeline for using degradome data to find cleaved small RNA targets'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7791818995713083609</id><published>2009-02-22T21:32:00.001+01:00</published><updated>2009-02-22T21:32:27.958+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='noncoding RNA'/><category scheme='http://www.blogger.com/atom/ns#' term='regulation of transcription'/><category scheme='http://www.blogger.com/atom/ns#' term='ENCODE'/><category scheme='http://www.blogger.com/atom/ns#' term='prediction'/><category scheme='http://www.blogger.com/atom/ns#' term='ncRNA'/><title type='text'>Conservation and implications of eukaryote transcriptional regulatory regions across multiple species</title><content type='html'>&lt;p&gt;&lt;a href="http://www.biomedcentral.com/1471-2164/9/623"&gt;Link to original article&lt;/a&gt;&lt;p&gt;Background:
Increasing evidence shows that whole genomes of eukaryotes are almost entirely transcribed into both protein coding genes and an enormous number of non-protein-coding RNAs (ncRNAs). Therefore, revealing the underlying regulatory mechanisms of transcripts becomes imperative. However, for a complete understanding of transcriptional regulatory mechanisms, we need to identify the regions in which they are found. We will call these transcriptional regulation regions, or TRRs, which can be considered functional regions containing a cluster of regulatory elements that cooperatively recruit transcriptional factors for binding and then regulating the expression of transcripts. &lt;/p&gt;
&lt;p&gt;Results:
We constructed a hierarchical stochastic language (HSL) model for the identification of core TRRs in yeast based on regulatory cooperation among TRR elements. The HSL model trained based on yeast achieved comparable accuracy in predicting TRRs in other species, e.g., fruit fly, human, and rice, thus demonstrating the conservation of TRRs across species. The HSL model was also used to identify the TRRs of genes, such as p53 or OsALYL1, as well as microRNAs. In addition, the ENCODE regions were examined by HSL, and TRRs were found to pervasively locate in the genomes. &lt;/p&gt;
&lt;p&gt;Conclusions:
Our findings indicate that 1) the HSL model can be used to accurately predict core TRRs of transcripts across species and 2) identified core TRRs by HSL are proper candidates for the further scrutiny of specific regulatory elements and mechanisms. Meanwhile, the regulatory activity taking place in the abundant numbers of ncRNAs might account for the ubiquitous presence of TRRs across the genome. In addition, we also found that the TRRs of protein coding genes and ncRNAs are similar in structure, with the latter being more conserved than the former.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.biomedcentral.com/bmcgenomics/"&gt;BMC Genomics  - Latest articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7791818995713083609?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7791818995713083609/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/conservation-and-implications-of.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7791818995713083609'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7791818995713083609'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/conservation-and-implications-of.html' title='Conservation and implications of eukaryote transcriptional regulatory regions across multiple species'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-6657719888277922745</id><published>2009-02-22T21:27:00.001+01:00</published><updated>2009-02-22T21:27:33.694+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='seed region'/><category scheme='http://www.blogger.com/atom/ns#' term='regulation of expression'/><category scheme='http://www.blogger.com/atom/ns#' term='noncoding RNA'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA host genes'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA expression'/><category scheme='http://www.blogger.com/atom/ns#' term='prediction'/><category scheme='http://www.blogger.com/atom/ns#' term='ncRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='anti-correlated expression'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='HOCTAR'/><title type='text'>MicroRNA target prediction by expression analysis of host genes</title><content type='html'>&lt;p&gt;&lt;a href="http://genome.cshlp.org/cgi/content/short/gr.084129.108v1?rss=1"&gt;Link to original article&lt;/a&gt;&lt;p&gt;MicroRNAs (miRNAs) are small non-coding RNAs that control gene expression by inducing RNA cleavage or translational inhibition. Most human miRNAs are intragenic and are transcribed as part of their hosting transcription units. &lt;/p&gt;&lt;p&gt;We hypothesized that the expression profiles of miRNA host genes and of their targets are inversely correlated and devised a novel procedure, HOCTAR (Host gene Oppositely Correlated TARgets), which ranks predicted miRNA target genes based on their anti-correlated expression behaviour relative to their respective miRNA host genes. HOCTAR is the first tool for systematic miRNA target prediction that utilizes the same set of microarray experiments to monitor the expression of both miRNAs (through their host genes) and candidate targets. &lt;/p&gt;&lt;p&gt;We applied the procedure to 178 human intragenic miRNAs and found that it performs better than currently available prediction softwares in pinpointing previously validated miRNA targets. The high-scoring HOCTAR predicted targets were enriched in Gene Ontology categories, which were consistent with previously published data, as in the case of miR-106b and miR-93. By means of overexpression and loss-of-function assays, we also demonstrated that HOCTAR is efficient in predicting novel miRNA targets and we identified, by microarray and qRT-PCR procedures, 34 and 28 novel targets for miR-26b and miR-98, respectively. &lt;/p&gt;&lt;p&gt;Overall, we believe that the use of HOCTAR significantly reduces the number of candidate miRNA targets to be tested compared to the procedures based solely on target sequence recognition. Finally, our data further confirm that miRNAs have a significant impact on the mRNA levels of most of their targets.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://genome.cshlp.org"&gt;GR-in-Advance&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-6657719888277922745?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/6657719888277922745/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/microrna-target-prediction-by.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/6657719888277922745'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/6657719888277922745'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/microrna-target-prediction-by.html' title='MicroRNA target prediction by expression analysis of host genes'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-5051313191627871666</id><published>2009-02-22T21:17:00.001+01:00</published><updated>2009-02-22T21:17:08.802+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='seed region'/><category scheme='http://www.blogger.com/atom/ns#' term='siRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='Watson-Crick pairing'/><category scheme='http://www.blogger.com/atom/ns#' term='G:U pair'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='off-target effect'/><title type='text'>Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect</title><content type='html'>&lt;p&gt;&lt;a href="http://nar.oxfordjournals.org/cgi/content/short/36/22/7100?rss=1"&gt;Link to original article&lt;/a&gt; &lt;p&gt;Short interfering RNA (siRNA) may down-regulate many unintended genes whose transcripts possess complementarity to the siRNA seed region, which contains 7 nt. The capability of siRNA to induce this off-target effect was highly correlated with the calculated melting temperature or standard free-energy change for formation of protein-free seed duplex, indicating that thermodynamic stability of seed duplex formed between the seed and target is one of the major factor in determining the degree of off-target effects. &lt;p&gt;Furthermore, unlike intended gene silencing (RNA interference), off-target effect was completely abolished by introduction of a G:U pair into the seed duplex, and this loss in activity was completely recovered by a second mutation regenerating Watson-Crick pairing, indicating that seed duplex Watson-Crick pairing is also essential for off-target gene silencing. The off-target effect was more sensitive to siRNA concentration compared to intended gene silencing, which requires a near perfect sequence match between the siRNA guide strand and target mRNA.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://nar.oxfordjournals.org"&gt;Nucleic Acids Research - current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-5051313191627871666?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/5051313191627871666/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/thermodynamic-stability-and-watson.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5051313191627871666'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5051313191627871666'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/thermodynamic-stability-and-watson.html' title='Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-1779208486465439748</id><published>2009-02-22T21:08:00.001+01:00</published><updated>2009-02-22T21:08:39.819+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='PKC'/><category scheme='http://www.blogger.com/atom/ns#' term='GF109203X'/><category scheme='http://www.blogger.com/atom/ns#' term='migration'/><category scheme='http://www.blogger.com/atom/ns#' term='PI3K'/><category scheme='http://www.blogger.com/atom/ns#' term='TPA'/><category scheme='http://www.blogger.com/atom/ns#' term='siRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='neuroblastoma'/><category scheme='http://www.blogger.com/atom/ns#' term='motility'/><category scheme='http://www.blogger.com/atom/ns#' term='protein kinase C'/><category scheme='http://www.blogger.com/atom/ns#' term='ERK  kinase'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Protein kinase C epsilon is important for migration of neuroblastoma cells</title><content type='html'>&lt;p&gt;&lt;a href="http://www.biomedcentral.com/1471-2407/8/365"&gt;Link to original article&lt;/a&gt; &lt;p&gt;Background:
Migration is important for the metastatic capacity and thus for the malignancy of cancer cells. There is limited knowledge on regulatory factors that promote the migration of neuroblastoma cells. This study investigates the hypothesis that protein kinase C (PKC) isoforms regulate neuroblastoma cell motility.&lt;/p&gt;
&lt;p&gt;Methods:
PKC isoforms were downregulated with siRNA or modulated with activators and inhibitors. Migration was analyzed with scratch and transwell assays. Protein phosphorylation and expression levels were measured with Western blot.&lt;/p&gt;
&lt;p&gt;Results:
Stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA) induced migration of SK-N-BE(2)C neuroblastoma cells. Treatment with the general protein kinase C (PKC) inhibitor GF109203X and the inhibitor of classical isoforms Go6976 inhibited migration while an inhibitor of PKC isoforms did not have an effect. Downregulation of PKC epsilon, but not of PKC alpha or PKC delta, with siRNA led to a suppression of both basal and TPA-stimulated migration. &lt;/p&gt;&lt;p&gt;Experiments using PD98059 and LY294002, inhibitors of the Erk and phosphatidylinositol 3-kinase (PI3K) pathways, respectively, showed that PI3K is not necessary for TPA-induced migration. The Erk pathway might be involved in TPA-induced migration but not in migration driven by PKC epsilon. TPA induced phosphorylation of the PKC substrate myristoylated alanine-rich C kinase substrate (MARCKS) which was suppressed by the PKC inhibitors. Treatment with siRNA oligonucleotides against different PKC isoforms before stimulation with TPA did not influence the phosphorylation of MARCKS.
&lt;/p&gt;&lt;p&gt;Conclusions:
PKC epsilon is important for migration of SK-N-BE(2)C neuroblastoma cells. Neither the Erk pathway nor MARCKS are critical downstream targets of PKC epsilon but they may be involved in TPA-mediated migration.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.biomedcentral.com"&gt;BioMed Central - Latest articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-1779208486465439748?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/1779208486465439748/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/protein-kinase-c-epsilon-is-important.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1779208486465439748'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1779208486465439748'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/protein-kinase-c-epsilon-is-important.html' title='Protein kinase C epsilon is important for migration of neuroblastoma cells'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-8179590220248980223</id><published>2009-02-22T21:00:00.001+01:00</published><updated>2009-02-22T21:00:51.282+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='functional genomics'/><category scheme='http://www.blogger.com/atom/ns#' term='MNT-1 cells'/><category scheme='http://www.blogger.com/atom/ns#' term='primary melanocytes'/><category scheme='http://www.blogger.com/atom/ns#' term='siRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='pigment'/><category scheme='http://www.blogger.com/atom/ns#' term='skin'/><title type='text'>Genome-Wide siRNA-Based Functional Genomics of Pigmentation Identifies Novel Genes and Pathways That Impact Melanogenesis in Human Cells</title><content type='html'>&lt;p&gt;&lt;a href="http://feeds.feedburner.com/~r/plosgenetics/NewArticles/~3/475643770/info%3Adoi/10.1371/journal.pgen.1000298"&gt;Link to original article&lt;/a&gt; &lt;p&gt;by Anand K. Ganesan, Hsiang Ho, Brian Bodemann, Sean Petersen, Jayavani Aruri, Shiney Koshy, Zachary Richardson, Lu Q. Le, Tatiana Krasieva, Michael G. Roth, Pat Farmer, Michael A. White&lt;/p&gt;
Author Summary

&lt;p&gt;Aberrant pigment regulation correlates with skin disorders, opthalmologic disorders, and neurologic disorders. While extensive studies have identified regulators of mouse coat color, the regulation of human skin phenotypic variation is less well understood. To give a broader picture of the molecular regulators of melanogenesis in human cells, we used a genome-wide siRNA functional genomics approach to identify 92 novel regulators of melanin production in heavily pigmented MNT-1 melanoma cells. &lt;/p&gt;&lt;p&gt;Our screen identified several genes that converge to regulate tyrosinase, the rate-limiting step in pigment production, in both MNT-1 cells and primary melanocytes. Some of the identified genes were selectively active in different genetic backgrounds, suggesting that they may regulate human phenotypic variation. Small molecule inhibition of a family of novel pigment regulators was sufficient to impair pigment production in melanocytes. &lt;/p&gt;&lt;p&gt;Additionally, our screen identified molecular machinery known to support autophagosome biosynthesis as putative regulators of melanogenesis. &lt;i&gt;In vitro&lt;/i&gt; co-localization studies and autophagy-deficient mice provided evidence that normal melanogenesis requires the same molecular machinery used by the autophagy pathway. &lt;/p&gt;&lt;p&gt;Taken together, these results illustrate the utility of genome wide siRNA screening approaches for identifying genes, novel pharmacologic agents, and pathways that regulate differentiated cellular phenotypes.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://genetics.plosjournals.org/perlserv/?request=get-rss&amp;issn=1553-7404&amp;type=new-articles"&gt;PLoS Genetics: Archived Table of Contents&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-8179590220248980223?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/8179590220248980223/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/genome-wide-sirna-based-functional.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8179590220248980223'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8179590220248980223'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/genome-wide-sirna-based-functional.html' title='Genome-Wide siRNA-Based Functional Genomics of Pigmentation Identifies Novel Genes and Pathways That Impact Melanogenesis in Human Cells'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-6936125283163932305</id><published>2009-02-22T20:48:00.001+01:00</published><updated>2009-02-22T20:48:38.542+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='endothelial cell'/><category scheme='http://www.blogger.com/atom/ns#' term='migration'/><category scheme='http://www.blogger.com/atom/ns#' term='siRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='motility'/><category scheme='http://www.blogger.com/atom/ns#' term='RNAi'/><title type='text'>Modular control of endothelial sheet migration</title><content type='html'>&lt;p&gt;&lt;a href="http://genesdev.cshlp.org/cgi/content/short/22/23/3268?rss=1"&gt;Link to original article&lt;/a&gt;&lt;/p&gt; &lt;p&gt;Growth factor-induced migration of endothelial cell monolayers enables embryonic development, wound healing, and angiogenesis. Although collective migration is widespread and therapeutically relevant, the underlying mechanism by which cell monolayers respond to growth factor, sense directional signals, induce motility, and coordinate individual cell movements is only partially understood. &lt;/p&gt;&lt;p&gt;Here we used RNAi to identify 100 regulatory proteins that enhance or suppress endothelial sheet migration into cell-free space. We measured multiple live-cell migration parameters for all siRNA perturbations and found that each targeted protein primarily regulates one of four functional outputs: cell motility, directed migration, cell-cell coordination, or cell density. We demonstrate that cell motility regulators drive random, growth factor-independent motility in the presence or absence of open space. &lt;/p&gt;&lt;p&gt;In contrast, directed migration regulators selectively transduce growth factor signals to direct cells along the monolayer boundary toward open space. Lastly, we found that regulators of cell-cell coordination are growth factor-independent and reorient randomly migrating cells inside the sheet when boundary cells begin to migrate. &lt;/p&gt;&lt;p&gt;Thus, cells transition from random to collective migration through a modular control system, whereby growth factor signals convert boundary cells into pioneers, while cells inside the monolayer reorient and follow pioneers through growth factor-independent migration and cell-cell coordination.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://genesdev.cshlp.org"&gt;Genes &amp; Development current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-6936125283163932305?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/6936125283163932305/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/modular-control-of-endothelial-sheet.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/6936125283163932305'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/6936125283163932305'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/modular-control-of-endothelial-sheet.html' title='Modular control of endothelial sheet migration'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7388828995112544768</id><published>2009-02-22T20:40:00.001+01:00</published><updated>2009-02-22T20:40:11.200+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='regulation of expression'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA target sites'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA seed'/><category scheme='http://www.blogger.com/atom/ns#' term='3&apos;UTR'/><category scheme='http://www.blogger.com/atom/ns#' term='TargetScan'/><category scheme='http://www.blogger.com/atom/ns#' term='prediction'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><title type='text'>Most mammalian mRNAs are conserved targets of microRNAs</title><content type='html'>&lt;p&gt;&lt;a href="http://genome.cshlp.org/cgi/content/short/gr.082701.108v2?rss=1"&gt;Link to original article&lt;/a&gt;&lt;/p&gt; &lt;p&gt;MicroRNAs (miRNAs) are small endogenous RNAs that pair to sites in mRNAs to direct post-transcriptional repression. Many sites that match the miRNA seed (nucleotides 2-7), particularly those in 3' untranslated regions (3'UTRs), are preferentially conserved. Here we overhauled our tool for finding preferential conservation of sequence motifs and applied it to the analysis of human 3'UTRs, increasing by nearly threefold the detected number of preferentially conserved miRNA target sites. &lt;/p&gt;&lt;p&gt;The new tool more efficiently incorporates new genomes and more completely controls for background conservation by accounting for mutational biases, dinucleotide conservation rates, and the conservation rates of individual UTRs. The improved background model enabled preferential conservation of a new site type, the 'offset 6mer,' to be detected. In total, &amp;gt;45,000 miRNA target sites within human 3'UTRs are conserved above background levels, and &amp;gt;60% of human protein-coding genes have been under selective pressure to maintain pairing to miRNAs. &lt;/p&gt;&lt;p&gt;Mammalian-specific miRNAs have far fewer conserved targets than do the more broadly conserved miRNAs, even when considering only more recently emerged targets. Although pairing to the 3' end of miRNAs can compensate for seed mismatches, this class of sites constitutes less than 2% of all preferentially conserved sites detected. The new tool enables statistically powerful analysis of individual miRNA target sites, with the probability of preferentially conserved targeting (&lt;I&gt;P&lt;/I&gt;&lt;SUB&gt;CT&lt;/SUB&gt;) correlating with experimental measurements of repression. &lt;/p&gt;&lt;p&gt;Our expanded set of target predictions (including conserved 3'-compensatory sites), are available at the TargetScan website, which displays the &lt;I&gt;P&lt;/I&gt;&lt;SUB&gt;CT&lt;/SUB&gt; for each site and each predicted target.&lt;/p&gt;&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://genome.cshlp.org"&gt;GR-in-Advance&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7388828995112544768?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7388828995112544768/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/most-mammalian-mrnas-are-conserved.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7388828995112544768'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7388828995112544768'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/most-mammalian-mrnas-are-conserved.html' title='Most mammalian mRNAs are conserved targets of microRNAs'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-1390996193271895153</id><published>2009-02-22T20:34:00.001+01:00</published><updated>2009-02-22T20:34:02.897+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='stem cells'/><category scheme='http://www.blogger.com/atom/ns#' term='regulation of expression'/><category scheme='http://www.blogger.com/atom/ns#' term='noncoding RNA'/><category scheme='http://www.blogger.com/atom/ns#' term='REST'/><category scheme='http://www.blogger.com/atom/ns#' term='transcriptional repressor'/><category scheme='http://www.blogger.com/atom/ns#' term='neuronal cells'/><category scheme='http://www.blogger.com/atom/ns#' term='ncRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='macroRNA'/><title type='text'>Regulation of neural macroRNAs by the transcriptional repressor REST</title><content type='html'>&lt;p&gt;&lt;a href="http://rnajournal.cshlp.org/cgi/content/short/rna.1127009v1?rss=1"&gt;Link to original article&lt;/a&gt;: &lt;p&gt;The essential transcriptional repressor REST (repressor element 1-silencing transcription factor) plays central roles in development and human disease by regulating a large cohort of neural genes. These have conventionally fallen into the class of known, protein-coding genes; recently, however, several noncoding microRNA genes were identified as REST targets. &lt;/p&gt;&lt;p&gt;Given the widespread transcription of messenger RNA-like, noncoding RNAs ('macroRNAs'), some of which are functional and implicated in disease in mammalian genomes, we sought to determine whether this class of noncoding RNAs can also be regulated by REST. By applying a new, unbiased target gene annotation pipeline to computationally discovered REST binding sites, we find that 23% of mammalian REST genomic binding sites are within 10 kb of a macroRNA gene. These putative target genes were overlooked by previous studies. &lt;/p&gt;&lt;p&gt;Focusing on a set of 18 candidate macroRNA targets from mouse, we experimentally demonstrate that two are regulated by REST in neural stem cells. Flanking protein-coding genes are, at most, weakly repressed, suggesting specific targeting of the macroRNAs by REST. Similar to the majority of known REST target genes, both of these macroRNAs are induced during nervous system development and have neurally restricted expression profiles in adult mouse. &lt;/p&gt;&lt;p&gt;We observe a similar phenomenon in human: the DiGeorge syndrome-associated noncoding RNA, &lt;I&gt;DGCR5&lt;/I&gt;, is repressed by REST through a proximal upstream binding site. Therefore neural macroRNAs represent an additional component of the REST regulatory network. These macroRNAs are new candidates for understanding the role of REST in neuronal development, neurodegeneration, and cancer.&lt;/p&gt;&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://rnajournal.cshlp.org"&gt;In Advance&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-1390996193271895153?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/1390996193271895153/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/regulation-of-neural-macrornas-by.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1390996193271895153'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1390996193271895153'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/regulation-of-neural-macrornas-by.html' title='Regulation of neural macroRNAs by the transcriptional repressor REST'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7543541176185043417</id><published>2009-02-22T20:25:00.001+01:00</published><updated>2009-02-22T20:25:42.207+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='stable duplex'/><category scheme='http://www.blogger.com/atom/ns#' term='microarray'/><category scheme='http://www.blogger.com/atom/ns#' term='PCR'/><category scheme='http://www.blogger.com/atom/ns#' term='oligonucleotide'/><title type='text'>Position dependent mismatch discrimination on DNA microarrays - experiments and model</title><content type='html'>&lt;p&gt;&lt;a href="http://www.biomedcentral.com/1471-2105/9/509"&gt;Link to original article&lt;/a&gt;&lt;/p&gt; &lt;p&gt;Background:
The propensity of oligonucleotide strands to form stable duplexes with complementary sequences is fundamental to a variety of biological and biotechnological processes as various as microRNA signalling, microarray hybridization and PCR. Yet our understanding of oligonucleotide  hybridization,  in particular in presence of surfaces, is rather limited. Here we use oligonucleotide microarrays made in-house by optically controlled DNA synthesis to produce probe sets comprising all possible single base mismatches and base bulges for each of  20 sequence motifs under study.&lt;/p&gt;
&lt;p&gt;Results:
We observe that mismatch discrimination is mostly determined by the defect position (relative to the duplex ends) as well as by the  sequence context. We investigate the thermodynamics of the oligonucleotide duplexes on the basis of double-ended molecular zipper. Theoretical predictions  of defect positional influence as well as long range sequence influence agree well with the experimental results.&lt;/p&gt;
&lt;p&gt;Conclusions:
Molecular zipping  at thermodynamic equilibrium explains the binding affinity of mismatched DNA duplexes on microarrays well. The position dependent nearest neighbor model (PDNN) can be inferred from it. Quantitative understanding of microarray experiments from first principles  is in reach.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.biomedcentral.com/bmcbioinformatics/"&gt;BMC Bioinformatics  - Latest articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7543541176185043417?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7543541176185043417/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/position-dependent-mismatch.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7543541176185043417'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7543541176185043417'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/position-dependent-mismatch.html' title='Position dependent mismatch discrimination on DNA microarrays - experiments and model'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7752296885101949282</id><published>2009-02-22T20:20:00.001+01:00</published><updated>2009-02-22T20:20:45.051+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='heart'/><category scheme='http://www.blogger.com/atom/ns#' term='miR-21'/><category scheme='http://www.blogger.com/atom/ns#' term='MAP kinase'/><category scheme='http://www.blogger.com/atom/ns#' term='antagomir'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='ERK  kinase'/><title type='text'>MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts</title><content type='html'>&lt;p&gt;&lt;a href="http://dx.doi.org/10.1038/nature07511"&gt;Link to original article&lt;/a&gt;:

&lt;p&gt;Authors: Thomas Thum, Carina Gross, Jan Fiedler, Thomas Fischer, Stephan Kissler, Markus Bussen, Paolo Galuppo, Steffen Just, Wolfgang Rottbauer, Stefan Frantz, Mirco Castoldi, Jürgen Soutschek, Victor Koteliansky, Andreas Rosenwald, M. Albert Basson, Jonathan D. Licht, John T. R. Pena, Sara H. Rouhanifard, Martina U. Muckenthaler, Thomas Tuschl, Gail R. Martin, Johann Bauersachs
&amp; Stefan Engelhardt&lt;/p&gt;
&lt;p&gt;MicroRNAs comprise a broad class of small non-coding RNAs that control expression of complementary target messenger RNAs. Dysregulation of microRNAs by several mechanisms has been described in various disease states including cardiac disease. Whereas previous studies of cardiac disease have focused on microRNAs that are primarily expressed in cardiomyocytes, the role of microRNAs expressed in other cell types of the heart is unclear. &lt;/p&gt;&lt;p&gt;Here we show that microRNA-21 (miR-21, also known as Mirn21) regulates the ERK-MAP kinase signalling pathway in cardiac fibroblasts, which has impacts on global cardiac structure and function. miR-21 levels are increased selectively in fibroblasts of the failing heart, augmenting ERK-MAP kinase activity through inhibition of sprouty homologue 1 (Spry1). This mechanism regulates fibroblast survival and growth factor secretion, apparently controlling the extent of interstitial fibrosis and cardiac hypertrophy. In vivo silencing of miR-21 by a specific antagomir in a mouse pressure-overload-induced disease model reduces cardiac ERK-MAP kinase activity, inhibits interstitial fibrosis and attenuates cardiac dysfunction. &lt;/p&gt;&lt;p&gt;These findings reveal that microRNAs can contribute to myocardial disease by an effect in cardiac fibroblasts. Our results validate miR-21 as a disease target in heart failure and establish the therapeutic efficacy of microRNA therapeutic intervention in a cardiovascular disease setting.&lt;/p&gt;&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.nature.com/nature/current_issue/"&gt;Nature&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7752296885101949282?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7752296885101949282/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/microrna-21-contributes-to-myocardial.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7752296885101949282'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7752296885101949282'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/microrna-21-contributes-to-myocardial.html' title='MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-74085364571393857</id><published>2009-02-22T20:15:00.001+01:00</published><updated>2009-02-22T20:15:00.307+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='high-throughput'/><category scheme='http://www.blogger.com/atom/ns#' term='RT-qPCR'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><title type='text'>High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA</title><content type='html'>&lt;p&gt;&lt;a href="http://nar.oxfordjournals.org/cgi/content/short/36/21/e143?rss=1"&gt;Link to original article&lt;/a&gt;&lt;/p&gt; &lt;p&gt;MicroRNAs (miRNAs) are an emerging class of small non-coding RNAs implicated in a wide variety of cellular processes. Research in this field is accelerating, and the growing number of miRNAs emphasizes the need for high-throughput and sensitive detection methods. &lt;/p&gt;&lt;p&gt;Here we present the successful evaluation of the Megaplex reverse transcription format of the stem-loop primer-based real-time quantitative polymerase chain reaction (RT-qPCR) approach to quantify miRNA expression. The Megaplex reaction provides simultaneous reverse transcription of 450 mature miRNAs, ensuring high-throughput detection. Further, the introduction of a complementary DNA pre-amplification step significantly reduces the amount of input RNA needed, even down to single-cell level. To evaluate possible pre-amplification bias, we compared the expression of 384 miRNAs in three different cancer cell lines with Megaplex RT, with or without an additional pre-amplification step. &lt;/p&gt;&lt;p&gt;The normalized Cq values of all three sample pairs showed a good correlation with maintenance of differential miRNA expression between the cell lines. Moreover, pre-amplification using 10 ng of input RNA enabled the detection of miRNAs that were undetectable when using Megaplex alone with 400 ng of input RNA. The high specificity of RT-qPCR together with a superior sensitivity makes this approach the method of choice for high-throughput miRNA expression profiling.&lt;/p&gt;&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://nar.oxfordjournals.org"&gt;Nucleic Acids Research - current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-74085364571393857?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/74085364571393857/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/high-throughput-stem-loop-rt-qpcr-mirna.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/74085364571393857'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/74085364571393857'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/high-throughput-stem-loop-rt-qpcr-mirna.html' title='High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-5446338743837899324</id><published>2009-02-22T20:10:00.001+01:00</published><updated>2009-02-22T20:10:42.426+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='gene discovery'/><category scheme='http://www.blogger.com/atom/ns#' term='pri-miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='CAGE'/><title type='text'>Annotation of Mammalian Primary microRNAs</title><content type='html'>&lt;p&gt;&lt;a href="http://www.biomedcentral.com/1471-2164/9/564"&gt;Link to original article&lt;/a&gt;: &lt;p&gt;Background:
MicroRNAs (miRNAs) are important regulators of gene expression and have been implicated in development, differentiation and pathogenesis. Hundreds of miRNAs have been discovered in mammalian genomes. Approximately 50% of mammalian miRNAs are expressed from introns of protein-coding genes; the primary transcript (pri-miRNA) is therefore assumed to be the host transcript. However, very little is known about the structure of pri-miRNAs expressed from intergenic regions. Here we annotate transcript boundaries of miRNAs in human, mouse and rat genomes using various transcription features. The 5' end of the pri-miRNA is predicted from transcription start sites, CpG islands and 5' CAGE tags mapped in the upstream flanking region surrounding the precursor miRNA (pre-miRNA). The 3' end of the pri-miRNA is predicted based on the mapping of polyA signals, and supported by cDNA/EST and ditags data. The predicted pri-miRNAs are also analyzed for promoter and insulator-associated regulatory regions.&lt;/p&gt;
&lt;p&gt;Results:
We define sets of conserved and non-conserved human, mouse and rat pre-miRNAs using bidirectional BLAST and synteny analysis. Transcription features in their flanking regions are used to demarcate the 5' and 3' boundaries of the pri-miRNAs. The lengths and boundaries of primary transcripts are highly conserved between orthologous miRNAs. A significant fraction of pri-miRNAs have lengths between 1 and 10kb, with very few introns. We annotate a total of 59 pri-miRNA structures, which include 82 pre-miRNAs. 36 pri-miRNAs are conserved in all 3 species. In total, 18 of the confidently annotated transcripts express more than one pre-miRNA. The upstream regions of 54% of the predicted pri-miRNAs are found to be associated with promoter and insulator regulatory sequences.&lt;/p&gt; 
&lt;p&gt;Conclusions:
Little is known about the primary transcripts of intergenic miRNAs. Using comparative data, we are able to identify the boundaries of a significant proportion of human, mouse and rat pri-miRNAs. We confidently predict the transcripts including a total of 77, 58 and 47 human, mouse and rat pre-miRNAs respectively. Our computational annotations provide a basis for subsequent experimental validation of predicted pri-miRNAs.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.biomedcentral.com"&gt;BioMed Central - Latest articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-5446338743837899324?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/5446338743837899324/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/annotation-of-mammalian-primary.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5446338743837899324'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5446338743837899324'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/annotation-of-mammalian-primary.html' title='Annotation of Mammalian Primary microRNAs'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-4043597466731734862</id><published>2009-02-22T20:07:00.001+01:00</published><updated>2009-02-22T20:07:01.227+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='stem cells'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='plasticity'/><category scheme='http://www.blogger.com/atom/ns#' term='multipotent stromal cells'/><category scheme='http://www.blogger.com/atom/ns#' term='LIF'/><category scheme='http://www.blogger.com/atom/ns#' term='mir 199'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='mir346'/><title type='text'>Human multipotent stromal cells from bone marrow and microRNA: Regulation of differentiation and leukemia inhibitory factor expression</title><content type='html'>&lt;p&gt;&lt;a href="http://www.pnas.org/cgi/content/short/105/47/18372?rss=1"&gt;Link to original article&lt;/a&gt;: &lt;/p&gt;&lt;p&gt;"We observed that microRNAs (miRNAs) that regulate differentiation in a variety of simpler systems also regulate differentiation of human multipotent stromal cells (hMSCs) from bone marrow. Differentiation of hMSCs into osteoblasts and adipocytes was inhibited by using lentiviruses expressing shRNAs to decrease expression of Dicer and Drosha, two enzymes that process early transcripts to miRNA. &lt;/p&gt;&lt;p&gt;Expression analysis of miRNAs during hMSC differentiation identified 19 miRNAs that were up-regulated during osteogenic differentiation and 20 during adipogenic differentiation, 11 of which were commonly up-regulated in both osteogenic and adipogenic differentiation. In silico models predicted that five of the up-regulated miRNAs targeted leukemia inhibitory factor (LIF) expression. &lt;/p&gt;&lt;p&gt;The prediction was confirmed for two of the miRNAs, hsa-mir 199a and hsa-mir346, in that over-expression of the miRNAs decreased LIF secretion by hMSCs. The results demonstrate that differentiation of hMSCs is regulated by miRNAs and that several of these miRNAs target LIF."&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.pnas.org"&gt;Proceedings of the National Academy of Sciences recent issues&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-4043597466731734862?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/4043597466731734862/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/human-multipotent-stromal-cells-from.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4043597466731734862'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4043597466731734862'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/human-multipotent-stromal-cells-from.html' title='Human multipotent stromal cells from bone marrow and microRNA: Regulation of differentiation and leukemia inhibitory factor expression'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-5986387286396882374</id><published>2009-02-22T19:57:00.001+01:00</published><updated>2009-02-22T19:57:46.242+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='exonucleolytic digestion'/><category scheme='http://www.blogger.com/atom/ns#' term='CAF1-CCR4-NOT1'/><category scheme='http://www.blogger.com/atom/ns#' term='deadenylation'/><category scheme='http://www.blogger.com/atom/ns#' term='decapping'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><title type='text'>[ARTICLE] Deadenylation is a widespread effect of miRNA regulation</title><content type='html'>&lt;p&gt;&lt;a href="http://rnajournal.cshlp.org/cgi/content/short/rna.1399509v1?rss=1"&gt;Link to original article&lt;/a&gt;: &lt;/p&gt;&lt;p&gt;miRNAs silence gene expression by repressing translation and/or by promoting mRNA decay. In animal cells, degradation of partially complementary miRNA targets occurs via deadenylation by the CAF1-CCR4-NOT1 deadenylase complex, followed by decapping and subsequent exonucleolytic digestion. &lt;/p&gt;&lt;p&gt;To determine how generally miRNAs trigger deadenylation, we compared mRNA expression profiles in &lt;I&gt;D. melanogaster&lt;/I&gt; cells depleted of AGO1, CAF1, or NOT1. We show that ~60% of AGO1 targets are regulated by CAF1 and/or NOT1, indicating that deadenylation is a widespread effect of miRNA regulation. However, neither a poly(A) tail nor mRNA circularization are required for silencing, because mRNAs whose 3' ends are generated by a self-cleaving ribozyme are also silenced in vivo. &lt;/p&gt;&lt;p&gt;We show further that miRNAs trigger mRNA degradation, even when binding by 40S ribosomal subunits is inhibited in &lt;I&gt;cis&lt;/I&gt;. These results indicate that miRNAs promote mRNA decay by altering mRNP composition and/or conformation, rather than by directly interfering with the binding and function of ribosomal subunits.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://rnajournal.cshlp.org"&gt;In Advance&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-5986387286396882374?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/5986387286396882374/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/article-deadenylation-is-widespread.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5986387286396882374'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5986387286396882374'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/article-deadenylation-is-widespread.html' title='[ARTICLE] Deadenylation is a widespread effect of miRNA regulation'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-8764346471605438479</id><published>2009-02-22T19:49:00.001+01:00</published><updated>2009-02-22T19:49:08.424+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='promoter'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA expression'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><title type='text'>[Research Papers] Chromatin structure analyses identify miRNA promoters</title><content type='html'>&lt;p&gt;&lt;a href="http://genesdev.cshlp.org/cgi/content/short/22/22/3172?rss=1"&gt;Link to original article&lt;/a&gt;:&lt;/p&gt; &lt;p&gt;Although microRNAs (miRNAs) are key regulators of gene expression in normal human physiology and disease, transcriptional regulation of miRNAs is poorly understood, because most miRNA promoters have not yet been characterized. We identified the proximal promoters of 175 human miRNAs by combining nucleosome mapping with chromatin signatures for promoters. &lt;/p&gt;&lt;p&gt;We observe that one-third of intronic miRNAs have transcription initiation regions independent from their host promoters and present a list of RNA polymerase II- and III-occupied miRNAs. Nucleosome mapping and linker sequence analyses in miRNA promoters permitted accurate prediction of transcription factors regulating miRNA expression, thus identifying nine miRNAs regulated by the MITF transcription factor/oncoprotein in melanoma cells. &lt;/p&gt;&lt;p&gt;Furthermore, DNA sequences encoding mature miRNAs were found to be preferentially occupied by positioned-nucleosomes, and the 3' end sites of known genes exhibited nucleosome depletion. The high-throughput identification of miRNA promoter and enhancer regulatory elements sheds light on evolution of miRNA transcription and permits rapid identification of transcriptional networks of miRNAs.&lt;/p&gt;&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://genesdev.cshlp.org"&gt;Genes &amp; Development current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-8764346471605438479?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/8764346471605438479/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/research-papers-chromatin-structure.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8764346471605438479'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/8764346471605438479'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/research-papers-chromatin-structure.html' title='[Research Papers] Chromatin structure analyses identify miRNA promoters'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-1955698063140442364</id><published>2009-02-22T19:41:00.001+01:00</published><updated>2009-02-22T19:44:05.222+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='p65'/><category scheme='http://www.blogger.com/atom/ns#' term='protein PU.1'/><category scheme='http://www.blogger.com/atom/ns#' term='miR-155'/><category scheme='http://www.blogger.com/atom/ns#' term='B-cell maturation'/><category scheme='http://www.blogger.com/atom/ns#' term='nuclear factor-kappa-B'/><title type='text'>Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-{kappa}B pathway</title><content type='html'>&lt;p&gt;&lt;a href="http://nar.oxfordjournals.org/cgi/content/short/36/20/6608?rss=1"&gt;Link to original article&lt;/a&gt;: &lt;p&gt;The Epstein-Barr virus (EBV)-encoded latent membrane protein-1 (LMP1), a functional homologue of the tumor necrosis factor receptor family, substantially contributes to EBV&lt;b&gt;'&lt;/b&gt;s oncogenic potential by activating nuclear factor-kappa-B (NF-kappa-B). miR-155 is an oncogenic miRNA critical for B-cell maturation and immunoglobulin production in response to antigen.&lt;/p&gt;&lt;/p&gt;We report that miR-155 expression is much higher in EBV-immortalized B cells than in EBV-negative B cells. LMP1, but not LMP2, up-regulated the expression of miR-155, when transfected in EBV-negative B cells. We analyzed two putative NF-kappa-B binding sites in the miR-155 promoter; both sites recruited NF-kappa-B complex, in nuclear extract from EBV-immortalized cells. The exogenous expression of LMP1, in EBV-negative background, is temporally correlated to induction of p65 with binding on both NF-kappa-B sites and with miR-155 overexpression. The induction of p65 binding together with increased RNA polymerase II binding, confirms that LMP1-mediated activation of miR-155 occurs transcriptionally. In reporter assays, miR-155 promoter lacking NF-kappa-B binding sites was no longer activated by LMP1 expression and an intact AP1 site is needed to attain maximum activation. &lt;/p&gt;&lt;/p&gt;Finally, we demonstrate that LMP1-mediated activation of miR-155 in an EBV-negative background correlates with reduction of protein PU.1, which is a possible miR target.&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://nar.oxfordjournals.org"&gt;Nucleic Acids Research - current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-1955698063140442364?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/1955698063140442364/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/epstein-barr-virus-latent-membrane.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1955698063140442364'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/1955698063140442364'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/epstein-barr-virus-latent-membrane.html' title='Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-{kappa}B pathway'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-3319538592558183275</id><published>2009-02-22T19:32:00.001+01:00</published><updated>2009-02-22T19:32:20.970+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='regulation of expression'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA expression'/><category scheme='http://www.blogger.com/atom/ns#' term='transcription factors'/><title type='text'>Analysis of regulatory network topology reveals functionally distinct classes of microRNAs</title><content type='html'>&lt;p&gt;&lt;a href="http://nar.oxfordjournals.org/cgi/content/short/36/20/6494?rss=1"&gt;Link to original article&lt;/a&gt;:&lt;p&gt;MicroRNAs (miRNAs) negatively regulate the expression of target genes at the post-transcriptional level. Little is known about the crosstalk between miRNAs and transcription factors (TFs). Here we provide data suggesting that the interaction patterns between TFs and miRNAs can influence the biological functions of miRNAs. From this global survey, we find that a regulated feedback loop, in which two TFs regulate each other and one miRNA regulates both of the factors, is the most significantly overrepresented network motif. &lt;/p&gt;&lt;p&gt;Mathematical modeling shows that the miRNA in this motif stabilizes the feedback loop to resist environmental perturbation, providing one mechanism to explain the robustness of developmental programs that is contributed by miRNAs. Furthermore, on the basis of a network motif profile analysis, we demonstrate the existence of two classes of miRNAs with distinct network topological properties. &lt;/p&gt;&lt;p&gt;The first class of miRNAs is regulated by a large number of TFs, whereas the second is regulated by only a few TFs. The differential expression level of the two classes of miRNAs in embryonic developmental stages versus adult tissues suggests that the two classes may have fundamentally different biological functions. Our results demonstrate that the TFs and miRNAs extensively interact with each other and the biological functions of miRNAs may be wired in the regulatory network topology.&lt;/p&gt;&lt;/p&gt;&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://nar.oxfordjournals.org"&gt;Nucleic Acids Research - current issue&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-3319538592558183275?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/3319538592558183275/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/analysis-of-regulatory-network-topology.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/3319538592558183275'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/3319538592558183275'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/analysis-of-regulatory-network-topology.html' title='Analysis of regulatory network topology reveals functionally distinct classes of microRNAs'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-5022546601774509592</id><published>2009-02-22T19:13:00.001+01:00</published><updated>2009-02-22T19:19:40.208+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='RNAseIII'/><category scheme='http://www.blogger.com/atom/ns#' term='helicase domain'/><category scheme='http://www.blogger.com/atom/ns#' term='short-hairpin RNAs'/><category scheme='http://www.blogger.com/atom/ns#' term='long-hairpin RNAs'/><category scheme='http://www.blogger.com/atom/ns#' term='DExH motif'/><category scheme='http://www.blogger.com/atom/ns#' term='stems in microRNAs'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='Dicer'/><title type='text'>A role for the Dicer helicase domain in the processing of thermodynamically unstable hairpin RNAs</title><content type='html'>&lt;p&gt;&lt;a href="http://nar.oxfordjournals.org/cgi/content/short/36/20/6511?rss=1"&gt;Link to original article&lt;/a&gt;: 
&lt;p&gt;In humans a single species of the RNAseIII enzyme Dicer processes both microRNA precursors into miRNAs and long double-stranded RNAs into small interfering RNAs (siRNAs). An interesting but poorly understood domain of the mammalian Dicer protein is the N-terminal helicase-like domain that possesses a signature DExH motif. Cummins &lt;I&gt;et al.&lt;/I&gt; created a human Dicer mutant cell line by inserting an AAV targeting cassette into the helicase domain of both Dicer alleles in HCT116 cells generating an in-frame 43-amino-acid insertion immediately adjacent to the DExH box. This insertion creates a Dicer mutant protein with defects in the processing of most, but not all, endogenous pre-miRNAs into mature miRNA. Using both biochemical and computational approaches, we provide evidence that the Dicer helicase mutant is sensitive to the thermodynamic properties of the stems in microRNAs and short-hairpin RNAs, with thermodynamically unstable stems resulting in poor processing and a reduction in the levels of functional mi/siRNAs. Paradoxically, this mutant exhibits enhanced processing efficiency and concomitant RNA interference when thermodynamically stable, long-hairpin RNAs are used. These results suggest an important function for the Dicer helicase domain in the processing of thermodynamically unstable hairpin structures.&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://nar.oxfordjournals.org"&gt;Nucleic Acids Research - current issue&lt;/a&gt;.)&lt;/p&gt;

&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-5022546601774509592?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/5022546601774509592/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/role-for-dicer-helicase-domain-in.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5022546601774509592'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5022546601774509592'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/role-for-dicer-helicase-domain-in.html' title='A role for the Dicer helicase domain in the processing of thermodynamically unstable hairpin RNAs'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7675444136718335287</id><published>2009-02-22T19:07:00.001+01:00</published><updated>2009-02-22T19:08:27.644+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='LooptomiR'/><category scheme='http://www.blogger.com/atom/ns#' term='miRNA processing'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><title type='text'>Posttranscriptional Regulation of miRNAs Harboring Conserved Terminal Loops</title><content type='html'>&lt;p&gt;&lt;a href="http://www.cell.com/molecular-cell/abstract/S1097-2765(08)00728-4"&gt;Posttranscriptional Regulation of miRNAs Harboring Conserved Terminal Loops&lt;/a&gt;: "Gracjan Michlewski, Sonia Guil, Colin A. Semple, Javier F. Cáceres."&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.cell.com"&gt;Molecular Cell&lt;/a&gt;.)&lt;/p&gt;

Summary: We recently found that hnRNP A1, a protein implicated in many aspects of RNA processing, acts as an auxiliary factor for the Drosha-mediated processing of a microRNA precursor, pri-miR-18a. Here, we provide the mechanism by which hnRNP A1 regulates this event. We show that hnRNP A1 binds to the loop of pri-miR-18a and induces a relaxation at the stem, creating a more favorable cleavage site for Drosha. We found that approximately 14% of all pri-miRNAs have highly conserved loops, which we predict act as landing pads for trans-acting factors influencing miRNA processing. In agreement, we show that 2O-methyl oligonucleotides targeting conserved loops (LooptomiRs) abolish miRNA processing invitro. Furthermore, we present evidence to support an essential role of conserved loops for pri-miRNA processing. Altogether, these data suggest the existence of auxiliary factors for the processing of specific miRNAs, revealing an additional level of complexity for the regulation of miRNA biogenesis.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7675444136718335287?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7675444136718335287/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/posttranscriptional-regulation-of.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7675444136718335287'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7675444136718335287'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/posttranscriptional-regulation-of.html' title='Posttranscriptional Regulation of miRNAs Harboring Conserved Terminal Loops'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-46527900423558041</id><published>2009-02-22T18:24:00.001+01:00</published><updated>2009-02-22T18:24:29.343+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='miRNA'/><category scheme='http://www.blogger.com/atom/ns#' term='ES cells'/><category scheme='http://www.blogger.com/atom/ns#' term='proliferation'/><category scheme='http://www.blogger.com/atom/ns#' term='Dgcr8'/><category scheme='http://www.blogger.com/atom/ns#' term='microRNA'/><title type='text'>Embryonic stem cell–specific microRNAs regulate the G1-S transition and promote rapid proliferation</title><content type='html'>&lt;p&gt;&lt;a href="http://dx.doi.org/10.1038/ng.250"&gt;Link to original article&lt;/a&gt;: "&lt;p&gt;
&lt;b&gt;Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation&lt;/b&gt;
&lt;/p&gt;
&lt;p&gt;Nature Genetics 40, 1478 (2008). &lt;a href="http://dx.doi.org/10.1038/ng.250"&gt;doi:10.1038/ng.250&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;Authors: Yangming Wang, Scott Baskerville, Archana Shenoy, Joshua E Babiarz, Lauren Baehner
&amp; Robert Blelloch&lt;/p&gt;
&lt;p&gt;Dgcr8 knockout embryonic stem (ES) cells lack microprocessor activity and hence all canonical microRNAs (miRNAs). These cells proliferate slowly and accumulate in G1 phase of the cell cycle. Here, by screening a comprehensive library of individual miRNAs in the background of the Dgcr8 knockout ES cells, we report that multiple ES cell-specific miRNAs, members of the miR-290 family, rescue the ES cell proliferation defect. Furthermore, rescued cells no longer accumulate in the G1 phase of the cell cycle. These miRNAs function by suppressing several key regulators of the G1-S transition. These results show that post-transcriptional regulation by miRNAs promotes the G1-S transition of the ES cell cycle, enabling rapid proliferation of these cells. Our screening strategy provides an alternative and powerful approach for uncovering the role of individual miRNAs in biological processes, as it overcomes the common problem of redundancy and saturation in the miRNA system.&lt;/p&gt;"&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.nature.com/ng/current_issue/"&gt;Nature Genetics&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-46527900423558041?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/46527900423558041/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/embryonic-stem-cellspecific-micrornas.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/46527900423558041'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/46527900423558041'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/embryonic-stem-cellspecific-micrornas.html' title='Embryonic stem cell–specific microRNAs regulate the G1-S transition and promote rapid proliferation'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-285540132758563346</id><published>2009-02-22T18:06:00.001+01:00</published><updated>2009-02-22T18:15:33.352+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='genital abnormalities'/><category scheme='http://www.blogger.com/atom/ns#' term='mental retardation'/><category scheme='http://www.blogger.com/atom/ns#' term='Potocki-Shaffer syndrome'/><category scheme='http://www.blogger.com/atom/ns#' term='microdeletion'/><category scheme='http://www.blogger.com/atom/ns#' term='seizure'/><category scheme='http://www.blogger.com/atom/ns#' term='human chromosome 11'/><category scheme='http://www.blogger.com/atom/ns#' term='WAGR syndrome'/><category scheme='http://www.blogger.com/atom/ns#' term='cataract'/><title type='text'>11p Microdeletion including WT1 but not PAX6, presenting with cataract, mental retardation, genital abnormalities and seizures: case report</title><content type='html'>&lt;p&gt;&lt;a href="http://www.molecularcytogenetics.org/content/2/1/6"&gt;Link to original article&lt;/a&gt;&lt;/p&gt; 

&lt;p&gt;"WAGR syndrome (Wilms' tumor, aniridia, genitourinary abnormalities and mental retardation) and Potocki-Shaffer syndrome are rare contiguous gene deletion syndromes caused by deletions of the 11p14-p12 chromosome region. 
We present a patient with mental retardation, unilateral cataract, bilateral ptosis, genital abnormalities, seizures and a dysmorphic face. Cytogenetic analysis showed a deletion on 11p that was further characterized using FISH and MLPA analyses. The deletion (11p13-p12) located in the area between the deletions associated with the WAGR and Potocki-Shaffer syndromes had a maximum size of 8.5 Mb and encompasses 44 genes. Deletion of WT1 explains the genital abnormalities observed. As PAX6 was intact the cataract observed cannot be explained by a deletion of this gene. Seizures have been described in Potocki-Shaffer syndrome while mental retardation has been described in both WAGR and Potocki-Shaffer syndrome. Characterization of this patient contributes further to elucidate the function of the genes in the 11p14-p12 chromosome region."&lt;/p&gt;

&lt;p&gt;(Via &lt;a href="http://www.biomedcentral.com"&gt;BioMed Central - Latest articles&lt;/a&gt;.)&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-285540132758563346?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/285540132758563346/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/11p-microdeletion-including-wt1-but-not.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/285540132758563346'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/285540132758563346'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/11p-microdeletion-including-wt1-but-not.html' title='11p Microdeletion including WT1 but not PAX6, presenting with cataract, mental retardation, genital abnormalities and seizures: case report'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-7027398177480966011</id><published>2009-02-22T17:33:00.002+01:00</published><updated>2009-02-22T17:46:20.275+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='cell growth'/><category scheme='http://www.blogger.com/atom/ns#' term='cell development'/><category scheme='http://www.blogger.com/atom/ns#' term='neuronal cells'/><category scheme='http://www.blogger.com/atom/ns#' term='cell growth arrest'/><title type='text'>Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth</title><content type='html'>By screening a fetal brain two-hybrid library with the death domain of the p75 neurotrophin receptor (NTR), we identified the Sall2 transcription factor as a novel interacting protein. Sall2 is a unique member of the Sall gene family, which is believed to be a tumour suppressor. Here, we show that Sall2 contains a p75NTR interaction domain not found in other Sall proteins and that p75NTR/Sall2 complexes co-immunoprecipitate from brain lysates. NGF dissociates p75NTR/Sall2 complexes and activates TrkA, which has an obligate function in the nuclear translocation of Sall2. NGF also increases Sall2 expression and this is mediated by p75NTR, but may not require TrkA. Depletion of Sall2 from cells decreases the expression and activity of p21(WAF1/CIP1), as well as the ability of NGF to induce growth arrest and the development of neurites. Overexpression of Sall2 activates p21(WAF1/CIP1), induces growth arrest, and promotes neurite outgrowth independently of NGF. These data establish Sall2 as a link between NTRs and transcriptional events that regulate the growth and development of neuronal cells.

&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19131967"&gt;Pubmed link&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-7027398177480966011?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/7027398177480966011/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/sall2-is-novel-p75ntr-interacting.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7027398177480966011'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/7027398177480966011'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/sall2-is-novel-p75ntr-interacting.html' title='Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-2301770177092583707</id><published>2009-02-22T17:28:00.000+01:00</published><updated>2009-02-22T17:30:50.515+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='copy number variation'/><category scheme='http://www.blogger.com/atom/ns#' term='allelic imbalance'/><category scheme='http://www.blogger.com/atom/ns#' term='microarray'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Genomic copy number determination in cancer cells from SNP microarrays based on quantitative genotyping corrected for aneuploidy</title><content type='html'>&lt;p&gt;[METHODS] Microarrays are frequently used to profile genome-wide copy number (CN) aberrations. While generally robust for detecting CN variants in germline DNA, the methods used to derive CN from signal intensity values have been suboptimal when applied to cancer genomes. The complexity of genomic aberrations in cancer makes it more difficult to discriminate between signal and noise, and measuring CN as a discrete variable does not account for tumor heterogeneity. Furthermore, standard normalization approaches detect CN changes relative to the overall DNA content, which is often not diploid in cancer. We propose an algorithm that uses the degree of allelic imbalance as well as probe intensity, with a correction for aneuploidy, for a quantitative CN assessment and scoring of allelic ratios. This algorithm results in a more precise definition of CN and allelic aberration in the cancer genome, which is essential for translational efforts focused on using these tools for molecular diagnostics and for the discovery of therapeutic targets.&lt;/p&gt;
&lt;a href="http://genome.cshlp.org/cgi/content/short/19/2/276?rss=1"&gt;Link to original article&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-2301770177092583707?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/2301770177092583707/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/genomic-copy-number-determination-in.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2301770177092583707'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2301770177092583707'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/genomic-copy-number-determination-in.html' title='Genomic copy number determination in cancer cells from SNP microarrays based on quantitative genotyping corrected for aneuploidy'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-5314491696952674023</id><published>2009-02-22T17:21:00.001+01:00</published><updated>2009-02-22T17:22:30.975+01:00</updated><title type='text'>Chromosomal instability mediated by non-B DNA: Cruciform conformation and not DNA sequence is responsible for recurrent translocation in humans</title><content type='html'>&lt;p&gt;Chromosomal aberrations have been thought to be random events. However, recent findings introduce a new paradigm in which certain DNA segments have the potential to adopt unusual conformations that lead to genomic instability and nonrandom chromosomal rearrangement. One of the best-studied examples is the palindromic AT-rich repeat (PATRR), which induces recurrent constitutional translocations in humans. Here, we established a plasmid-based model that promotes frequent intermolecular rearrangements between two PATRRs in HEK293 cells. In this model system, the proportion of PATRR plasmid that extrudes a cruciform structure correlates to the levels of rearrangement. Our data suggest that PATRR-mediated translocations are attributable to unusual DNA conformations that confer a common pathway for chromosomal rearrangements in humans.&lt;/p&gt;&lt;p&gt;
&lt;/p&gt;&lt;a href="http://genome.cshlp.org/cgi/content/short/19/2/191?rss=1"&gt;Link to original article&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-5314491696952674023?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/5314491696952674023/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/chromosomal-instability-mediated-by-non.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5314491696952674023'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5314491696952674023'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/chromosomal-instability-mediated-by-non.html' title='Chromosomal instability mediated by non-B DNA: Cruciform conformation and not DNA sequence is responsible for recurrent translocation in humans'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-2803451321411580689</id><published>2009-02-22T17:12:00.000+01:00</published><updated>2009-02-22T17:19:23.956+01:00</updated><title type='text'>Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites</title><content type='html'>&lt;p&gt;Background: Gene rearrangements such as chromosomal translocations have been shown to contribute to cancer development.  Human chromosomal fragile sites are regions of the genome especially prone to breakage, and have been implicated in various chromosome abnormalities found in cancer.  However, there has been no comprehensive and quantitative examination of the location of fragile sites in relation to all chromosomal aberrations.&lt;/p&gt;&lt;p&gt;Results: Using up-to-date databases containing all cancer-specific recurrent translocations, we have examined 444 unique pairs of genes involved in these translocations to determine the correlation of translocation breakpoints and fragile sites in the gene pairs.  We found that over half (52%) of translocation breakpoints in at least one gene of these gene pairs are mapped to fragile sites. Among these, we examined the DNA sequences within and flanking three randomly selected pairs of translocation-prone genes, and found that they exhibit characteristic features of fragile DNA, with frequent AT-rich flexibility islands and the potential of forming highly stable secondary structures.&lt;/p&gt;&lt;p&gt;Conclusions: Our study is the first to examine gene pairs involved in all recurrent chromosomal translocations observed in tumor cells, and to correlate the location of more than half of breakpoints to positions of known fragile sites.  These results provide strong evidence to support a causative role for fragile sites in the generation of cancer-specific chromosomal rearrangements.&lt;/p&gt;&lt;a href="http://www.biomedcentral.com/1471-2164/10/59"&gt;Link to original article&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-2803451321411580689?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/2803451321411580689/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/over-half-of-breakpoints-in-gene-pairs.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2803451321411580689'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/2803451321411580689'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/over-half-of-breakpoints-in-gene-pairs.html' title='Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-5609316977547661095</id><published>2009-02-22T17:04:00.002+01:00</published><updated>2009-02-22T17:12:27.729+01:00</updated><title type='text'>Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis ...</title><content type='html'>&lt;p&gt;Background: Microarray genome analysis is realising its promise for improving detection of genetic abnormalities in individuals with mental retardation and congenital abnormality. Copy number variations (CNVs) are now readily detectable using a variety of platforms and a major challenge is the distinction of pathogenic from ubiquitous, benign polymorphic CNVs. The aim of this study was to investigate replacement of time consuming, locus specific testing for specific microdeletion and microduplication syndromes with microarray analysis, which theoretically should detect all known syndromes with CNV aetiologies as well as new ones.&lt;/p&gt;

&lt;p&gt;Methods: Genome wide copy number analysis was performed on 117 patients using Affymetrix 250K microarrays.&lt;/p&gt;

&lt;p&gt;Results: 434 CNVs (195 losses and 239 gains) were found, including 18 pathogenic CNVs and 9 identified as "potentially pathogenic". Almost all pathogenic CNVs were larger than 500 kb, significantly larger than the median size of all CNVs detected. Segmental regions of loss of heterozygosity larger than 5 Mb were found in 5 patients.&lt;/p&gt;

&lt;p&gt;Conclusions: Genome microarray analysis has improved diagnostic success in this group of patients. Several examples of recently discovered "new syndromes" were found suggesting they are more common than previously suspected and collectively are likely to be a major cause of mental retardation. The findings have several implications for clinical practice. The study revealed the potential to make genetic diagnoses that were not evident in the clinical presentation, with implications for pretest counselling and the consent process. The importance of contributing novel CNVs to high quality databases for genotype–phenotype analysis and review of guidelines for selection of individuals for microarray analysis is emphasised.&lt;/p&gt;

&lt;a href="http://jmg.bmj.com/cgi/content/short/46/2/123?rss=1"&gt;Link to original article&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-5609316977547661095?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/5609316977547661095/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/detection-of-cryptic-pathogenic-copy.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5609316977547661095'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/5609316977547661095'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/detection-of-cryptic-pathogenic-copy.html' title='Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis ...'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2304442315458153295.post-4461737452814430864</id><published>2009-02-22T16:27:00.004+01:00</published><updated>2009-02-22T16:49:07.027+01:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='down syndrome chromosome 1'/><title type='text'>Unbalanced chromosome 1 abnormalities in four infants with Down syndrome and acute megakaryocytic leukemia</title><content type='html'>&lt;p&gt;Background: Children with Down syndrome have an increased risk of childhood acute leukemia, especially acute megakaryoblastic leukemia (AMKL) also called acute myeloid leukemia (AML) type M7. Here four yet unreported infants with such malignancies are reported.&lt;/p&gt;
&lt;p&gt;Results: An unbalanced translocation involving chromosome 1 was identified by GTG banding in all cases. These were characterized in more detail by molecular cytogenetic approaches and hints were found on a critical region in 1q31~32. Additional molecular analysis revealed in three of the four cases mutations in exon 2 of the GATA binding protein 1 (globin transcription factor 1), located in Xp11.23.&lt;/p&gt;
&lt;p&gt;Conclusions: Our results corroborate that abnormalities of chromosome 1 are common in DS-associated AMKL. Whether this chromosomal region contains gene(s) involved in hematopoietic malignant transformation remains to be determined.&lt;/p&gt;
&lt;a href="http://www.molecularcytogenetics.org/content/2/1/7"&gt;Link to original article&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2304442315458153295-4461737452814430864?l=downsyndromeblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://downsyndromeblog.blogspot.com/feeds/4461737452814430864/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/unbalanced-chromosome-1-abnormalities.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4461737452814430864'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2304442315458153295/posts/default/4461737452814430864'/><link rel='alternate' type='text/html' href='http://downsyndromeblog.blogspot.com/2009/02/unbalanced-chromosome-1-abnormalities.html' title='Unbalanced chromosome 1 abnormalities in four infants with Down syndrome and acute megakaryocytic leukemia'/><author><name>Radek Blatny</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>
